Tag
Moderna and Merck announced the success of their mRNA cancer vaccine in a Phase 3 melanoma trial, which could establish a new personalized treatment paradigm for cancer.
Moderna and Merck announced positive Phase 3 results for their personalized cancer vaccine, which reduced melanoma recurrence, causing Moderna stock to surge by over 110%.
Moderna and Merck announced positive Phase 3 results for intismeran autogene, an mRNA-based individualized neoantigen therapy, in adjuvant treatment for melanoma.
Researchers have identified the first documented case of a transmissible melanoma in brown catfish, marking the first contagious cancer found in fish and in a freshwater ecosystem.
Pioneering Australian melanoma doctor Richard Scolyer has died at 59 after undergoing a world-first experimental immunotherapy treatment for glioblastoma. His work with Georgina Long dramatically improved survival rates for advanced melanoma patients.